Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TherapeuticsMD, Inc. | Prin. Fin. and Acctg. Officer | Common Stock | 61.9K | $138K | $2.24 | Apr 12, 2023 | Direct |
TherapeuticsMD, Inc. | Prin. Fin. and Acctg. Officer | Restricted Stock Units | 0 | $3.64 | Apr 12, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TXMD | TherapeuticsMD, Inc. | Apr 12, 2023 | 2 | $0 | 4 | Apr 14, 2023 | Prin. Fin. and Acctg. Officer |
TXMD | TherapeuticsMD, Inc. | Feb 21, 2023 | 1 | $0 | 4 | Feb 23, 2023 | Prin. Fin. and Acctg. Officer |
TXMD | TherapeuticsMD, Inc. | Jan 26, 2023 | 8 | -$8.62K | 4 | Jan 30, 2023 | Prin. Fin. and Acctg. Officer |
TXMD | TherapeuticsMD, Inc. | Jan 23, 2023 | 10 | -$6.99K | 4 | Jan 25, 2023 | Prin. Fin. and Acctg. Officer |
TXMD | TherapeuticsMD, Inc. | Dec 6, 2022 | 9 | -$4.35K | 4 | Dec 9, 2022 | Interim CFO/CAO/VP of Finance |
TXMD | TherapeuticsMD, Inc. | Mar 31, 2022 | 1 | $0 | 4 | Mar 31, 2022 | CAO and VP of Finance |
TXMD | TherapeuticsMD, Inc. | Mar 23, 2022 | 1 | $0 | 4 | Mar 28, 2022 | CAO and VP of Finance |
TXMD | TherapeuticsMD, Inc. | Nov 30, 2021 | 3 | -$15.9K | 4 | Dec 2, 2021 | CAO and VP of Finance |
TXMD | TherapeuticsMD, Inc. | Sep 29, 2021 | 5 | $0 | 4 | Oct 1, 2021 | CAO and VP of Finance |
TXMD | TherapeuticsMD, Inc. | Jul 1, 2021 | 2 | $0 | 4 | Jul 2, 2021 | CAO and VP Finance |
TXMD | TherapeuticsMD, Inc. | May 10, 2021 | 3 | -$5.04K | 4 | May 12, 2021 | CAO and VP Finance |